These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6194261)

  • 41. Vasoactive intestinal peptide stimulates cyclic AMP metabolism in choroid plexus epithelial cells.
    Crook RB; Prusiner SB
    Brain Res; 1986 Oct; 384(1):138-44. PubMed ID: 3024776
    [TBL] [Abstract][Full Text] [Related]  

  • 42. GABAB receptor-mediated enhancement of vasoactive intestinal peptide-stimulated cyclic AMP production in slices of rat cerebral cortex.
    Watling KJ; Bristow DR
    J Neurochem; 1986 Jun; 46(6):1755-62. PubMed ID: 3009716
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vasoactive intestinal polypeptide and alpha 2-adrenoceptor agonists regulate adenosine 3',5'-monophosphate accumulation and melatonin release in chick pineal cell cultures.
    Pratt BL; Takahashi JS
    Endocrinology; 1989 Nov; 125(5):2375-84. PubMed ID: 2477231
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vasoactive intestinal peptide receptor antagonist [4Cl-D-Phe6, Leu17] VIP.
    Pandol SJ; Dharmsathaphorn K; Schoeffield MS; Vale W; Rivier J
    Am J Physiol; 1986 Apr; 250(4 Pt 1):G553-7. PubMed ID: 2421587
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vasoactive intestinal peptide- and adrenocorticotropin-stimulated adenyl cyclase in cultured adrenal tumor cells: evidence for a specific vasoactive intestinal peptide receptor.
    Birnbaum RS; Alfonzo M; Kowal J
    Endocrinology; 1980 Apr; 106(4):1270-5. PubMed ID: 6244149
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dopamine-stimulated cyclic AMP and binding of [3H] dopamine in acini from dog pancreas.
    Vaysse N; Laval J; Senarens C; Esteve JP; Ribet A
    Biochim Biophys Acta; 1982 Jul; 720(4):378-83. PubMed ID: 6180776
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Homologous regulation of adenylate cyclase-coupled receptors for vasoactive intestinal peptide (VIP) on human mononuclear leucocytes.
    Wiik P
    Regul Pept; 1988 Apr; 20(4):323-33. PubMed ID: 2835796
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vasoactive intestinal peptide actions on cyclic AMP levels in cultured striatal neurons.
    Weiss S; Sebben M; Kemp DE; Bockaert J
    Peptides; 1986; 7 Suppl 1():187-92. PubMed ID: 3018697
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regulation of growth hormone release in common carp pituitary cells by pituitary adenylate cyclase-activating polypeptide: signal transduction involves cAMP- and calcium-dependent mechanisms.
    Xiao D; Chu MM; Lee EK; Lin HR; Wong AO
    Neuroendocrinology; 2002 Nov; 76(5):325-38. PubMed ID: 12457043
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of VIP receptors in mouse peritoneal macrophages: functional and molecular characterization.
    Calvo JR; Montilla ML; Guerrero JM; Segura JJ
    J Neuroimmunol; 1994 Feb; 50(1):85-93. PubMed ID: 8300860
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vasoactive intestinal peptide stimulates androgen biosynthesis by cultured neonatal testicular cells.
    Kasson BG; Lim P; Hsueh AJ
    Mol Cell Endocrinol; 1986 Nov; 48(1):21-9. PubMed ID: 2430845
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of vasoactive intestinal peptide receptors on rat alveolar macrophages.
    Sakakibara H; Shima K; Said SI
    Am J Physiol; 1994 Sep; 267(3 Pt 1):L256-62. PubMed ID: 7943252
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regulation of the rat proopiomelanocortin gene expression in AtT-20 cells. II: Effects of the pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide.
    Aoki Y; Iwasaki Y; Katahira M; Oiso Y; Saito H
    Endocrinology; 1997 May; 138(5):1930-4. PubMed ID: 9112389
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential expression of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs.
    Rawlings SR; Piuz I; Schlegel W; Bockaert J; Journot L
    Endocrinology; 1995 May; 136(5):2088-98. PubMed ID: 7720658
    [TBL] [Abstract][Full Text] [Related]  

  • 55. VIP-induced relaxation of guinea-pig intestinal smooth muscle cells: sequential involvement of cyclic AMP and nitric oxide.
    Rekik M; Delvaux M; Tack I; Frexinos J; Bueno L
    Br J Pharmacol; 1996 Jun; 118(3):477-84. PubMed ID: 8762068
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells.
    Gespach C; Bawab W; de Cremoux P; Calvo F
    Cancer Res; 1988 Sep; 48(18):5079-83. PubMed ID: 2842044
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interaction of peptides related to VIP and secretin with guinea pig pancreatic acini.
    Zhou ZC; Gardner JD; Jensen RT
    Am J Physiol; 1989 Feb; 256(2 Pt 1):G283-90. PubMed ID: 2465694
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evidence for a cyclic AMP system highly sensitive to secretin in gastric glands isolated from the rat fundus and antrum.
    Gespach C; Bataille D; Dupont C; Rosselin G; Wünsch E; Jaeger E
    Biochim Biophys Acta; 1980 Jul; 630(3):433-41. PubMed ID: 6249385
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A human melanoma-derived cell line (IGR39) with a very high number of vasoactive-intestinal-peptide (VIP) receptors. 2. Effect of VIP on cAMP production and on cell-surface VIP-binding sites.
    Martin JM; Luis J; Marvaldi J; Pichon J; Pic P
    Eur J Biochem; 1989 Mar; 180(2):435-9. PubMed ID: 2538331
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stimulation of retinal adenylate cyclase by vasoactive intestinal peptide (VIP).
    Longshore MA; Makman MH
    Eur J Pharmacol; 1981 Mar; 70(2):237-40. PubMed ID: 7262187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.